TERT (Telomerase Reverse Transcriptase) encodes the catalytic subunit of telomerase, an enzyme that maintains telomere length. While primarily studied in cancer biology, TERT has emerging connections to neurodegeneration through its roles in cellular senescence, mitochondrial function, and neural stem cell biology.
| TERT |
|---|
| Gene Symbol | TERT |
| Full Name | Telomerase Reverse Transcriptase |
| Chromosome | 5p15.33 |
| NCBI Gene ID | 7015 |
| OMIM | 607409 |
| Ensembl ID | ENSG00000164362 |
| UniProt ID | O14748 |
TERT is the reverse transcriptase component of telomerase, an enzyme that adds telomeric DNA repeats to chromosome ends. In most somatic cells, TERT is silenced after development, but its reactivation is a hallmark of cancer. Recent research suggests TERT may have functions beyond telomere maintenance that are relevant to neuronal biology and neurodegeneration.
TERT, together with TERC (the RNA template) and other proteins, forms the active telomerase complex:
- Reverse transcriptase activity: Adds TTAGGG repeats to telomeres
- Processivity: Maintains telomere length through cell divisions
- Regulation: Tightly regulated at transcriptional and post-translational levels
Emerging evidence suggests TERT has functions independent of telomerase:
- Mitochondrial localization: TERT localizes to mitochondria and may affect mitochondrial function
- Gene expression regulation: Can act as a transcription co-factor
- Cellular metabolism: Affects glycolysis and oxidative phosphorylation
- Neuroprotection: May protect neurons from various stressors
- Embryonic stem cells: High TERT expression
- Somatic cells: Generally silenced after development
- Neural stem cells: Maintains proliferative capacity
- Neural progenitor cells: Higher expression
- Neurons: Low to undetectable
- Glia: Variable expression
TERT reactivation is common in:
- Most cancers
- Tumor progression
- Therapeutic resistance
Connections to neurodegenerative diseases include:
- Alzheimer's disease: Altered TERT in brain tissue
- Parkinson's disease: Possible mitochondrial dysfunction links
- Aging: Telomere shortening and cellular senescence
- Aplastic anemia: TERT mutations
- Pulmonary fibrosis: TERT variants
- Dyskeratosis congenita: TERT mutations
- Telomerase inhibitors in development
- Immunotherapy approaches
- G-quadruplex stabilizers
Potential therapeutic approaches:
- Mitochondrial-targeted TERT modulators
- Senolytic strategies
- Stem cell therapies
Telomere shortening is associated with cellular aging and has been implicated in Alzheimer's disease pathogenesis:
- Cellular senescence: Accelerated telomere shortening in AD brains correlates with increased senescent cell burden
- Neuronal vulnerability: Telomere长度减少 may make neurons more susceptible to oxidative stress
- Glial senescence: Senescent astrocytes and microglia show heightened inflammatory responses
Emerging research suggests connections between TERT and Parkinson's disease:
- Mitochondrial dysfunction: TERT's mitochondrial localization may influence PD-related mitochondrial defects
- Autophagy regulation: TERT may affect mitophagy pathways implicated in PD
- Alpha-synuclein aggregation: Some studies suggest telomere dysfunction may promote aggregation
¶ Neurogenesis and Neural Stem Cells
TERT plays important roles in neural biology:
- Stem cell maintenance: TERT supports neural progenitor cell proliferation
- Neurogenesis: Required for proper hippocampal neurogenesis in some contexts
- Regeneration potential: TERT activity may enhance neural repair capacity
¶ Aging and Neurodegeneration
The intersection of aging, telomeres, and neurodegeneration:
- Accelerated aging: Short telomeres are a marker of biological aging
- DNA damage accumulation: Telomere dysfunction triggers DNA damage responses
- Cellular energy metabolism: TERT affects mitochondrial function and cellular energetics
- Mitochondrial TERT: Localization to mitochondria provides neuroprotective effects through enhanced ATP production and reduced ROS
- Neuroinflammation: TERT modulates microglial activation and neuroinflammatory responses
- Neural plasticity: TERT expression correlates with synaptic plasticity markers
- Telomerase-based therapeutics for age-related neurodegeneration
- Gene therapy approaches to restore TERT function
- Small molecule modulators of telomerase activity
The study of Tert Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Shay & Wright, Nature Reviews Cancer (2019)
- Cong & Shay, Cell (2008)
- Saretzki, Ageing Research Reviews (2014)
- Ahmed et al., Cell (2008)
- Park et al., Nature (2019)
- Fischer & Greider, Nature (2015)
- Bernardes de Jesus et al., EMBO Molecular Medicine (2012)
- Jaskelioff et al., Nature (2011)
- Saretzki, Journal of Alzheimer's Disease (2018)
- Eitan et al., Neurobiology of Aging (2017)